<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03482674</url>
  </required_header>
  <id_info>
    <org_study_id>01NVF17012</org_study_id>
    <nct_id>NCT03482674</nct_id>
  </id_info>
  <brief_title>DIMINI - Diabetes Mellitus? - Not me!</brief_title>
  <acronym>Dimini</acronym>
  <official_title>DIMINI - Activating of Health Literacy in Persons With an Increased Risk of Type 2 Diabetes Mellitus by Coaching at General Practitioners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dimini Konsortium</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Deutsche Diabetes Gesellschaft</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dimini Konsortium</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The increasing prevalence of type 2 diabetes mellitus is a worldwide problem. In preventing&#xD;
      risk factors and unhealthy lifestyle through improved health literacy, chances are seen to&#xD;
      delay or even avoid type 2 diabetes mellitus. The aim of the DIMINI-project is to prevent&#xD;
      type 2 diabetes mellitus and to strengthen the health literacy of people at increased risk of&#xD;
      developing it. For this purpose, people at increased risk are first identified by using the&#xD;
      standardized screening tool Finnish Diabetes Risk Score (FINDRISC) adapted for Germany.&#xD;
      Identified risk persons then receive a needs-based, modular lifestyle intervention including&#xD;
      nutrition tips and physical exercises either paper- or app-based.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      DIMINI, a randomised controlled trial, will assess whether the implementation of a lifestyle&#xD;
      intervention for people at increased risk of developing type 2 diabetes mellitus will result&#xD;
      in an improvement in body weight (primary outcome) and participants health literacy&#xD;
      (secondary outcome) or not. A three-month intervention in the intervention group is followed&#xD;
      by a one-year follow-up. The control group receives standard care as provided by the German&#xD;
      statutory health insurance for three months and a one-year follow-up as well.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">January 2, 2018</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight reduction</measure>
    <time_frame>15 Months</time_frame>
    <description>Survey of weight general practitioners level</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Health literacy (European Health Literacy Survey Questionnaire)</measure>
    <time_frame>15 Months</time_frame>
    <description>Summed scale:&#xD;
Maximum: 16 (best health literacy)&#xD;
Minimum: 0 (worst health literacy)&#xD;
≥ 13 = sufficient health literacy&#xD;
9-12 = problematic health literacy&#xD;
≤ 8 = inadequate health literacy Higher values represent a better outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Eating behaviour (German questionnaire on eating behaviour)</measure>
    <time_frame>15 Months</time_frame>
    <description>Three summed subscales:&#xD;
Scale 1) cognitive control of eating behavior, restrained eating&#xD;
Minimum score: 0 = no cognitive control&#xD;
Maximum score: 21 = extreme cognitive control Scale 2) disturbance of eating behavior&#xD;
Minimum score: 0 = no disturbance&#xD;
Maximum score: 16 = extreme disturbance Scale 3) experienced feelings of hunger&#xD;
Minimum score: 0 = no disturbing sensations of hunger&#xD;
Maximum score: 14 = very strong disturbing sensations of hunger For each item it is determined individually, which response option is considered to get a value of 1 or a value of 0 (e.g. Scale 1 Item 12: &quot;true&quot; = 1, &quot;not true&quot; = 0, Item 18 &quot;true&quot; = 0, &quot;not true&quot; = 1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity (International Physical Activity Questionnaire)</measure>
    <time_frame>15 Months</time_frame>
    <description>Questionnaire designed for population surveillance of physical activity among adults including&#xD;
Total Score:&#xD;
Maximum Score: 960 minutes&#xD;
Minimum Score: 10 minutes&#xD;
Categorical Score:&#xD;
Category 1 - Low:&#xD;
• Individuals who not meet criteria for Categories 2 or 3&#xD;
Category 2 - Moderate:&#xD;
3 or more days of vigorous-intensity activity of at least 20 minutes per day&#xD;
5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day&#xD;
5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 minutes/week.&#xD;
Category 3 High&#xD;
vigorous-intensity activity on at least 3 days achieving a minimum total physical activity of at least 1500 minutes/week&#xD;
7 or more days of any combination of walking, moderate-intensity or vigorous-intensity activities achieving a minimum total physical activity of at least 3000 minutes/week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>15 Months</time_frame>
    <description>Short Form 12</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">530</enrollment>
  <condition>Health Behavior</condition>
  <condition>Health Knowledge, Attitudes, Practice</condition>
  <condition>Literacy</condition>
  <condition>Diabetes Mellitus, Type 2</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group will receive standard care as provided by the German statutory health insurance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention group receives the DIMINI lifestyle intervention for a period of three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DIMINI lifestyle intervention</intervention_name>
    <description>DIMINI lifestyle intervention consists of the DIMINI-kit which contains health information, a list of food recommendations with additional information on calories, serving size and weight (traffic light rating system), a nutrition and an exercise diary. Participants in the intervention group can choose between a paper-based version or an app-based version of the DIMINI-kit. In addition, the kit includes an elastic exercise band with exercise poster, a measuring tape for self-control of the waist size and a pedometer.</description>
    <arm_group_label>Intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ≥ 18 years&#xD;
&#xD;
          -  resident in Hesse or Schleswig-Holstein&#xD;
&#xD;
          -  statutory health insurance in one out of five participating health insurances&#xD;
&#xD;
          -  overweight/obesity&#xD;
&#xD;
          -  low physical activity&#xD;
&#xD;
          -  known family disposition for type 2 diabetes mellitus&#xD;
&#xD;
          -  history of increased glucose levels&#xD;
&#xD;
          -  FINDRISC results with scores ≥ 12&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt; 18 years&#xD;
&#xD;
          -  resident outside Hesse or Schleswig-Holstein&#xD;
&#xD;
          -  statutory or private health insurance with other than the participating health&#xD;
             insurances&#xD;
&#xD;
          -  clinically manifested diabetes mellitus&#xD;
&#xD;
          -  malnutrition&#xD;
&#xD;
          -  psychiatric disorders&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  FINDRISC results with scores &lt;12&#xD;
&#xD;
          -  participation in other clinical trials&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carsten Petersen, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>docevent GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carsten Petersen, Dr.</last_name>
    <phone>+494621-855 425</phone>
    <email>c.petersen@internisten-schleswig.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Volker E Amelung, Prof. Dr.</last_name>
    <phone>+4930-24631222</phone>
    <email>info@inav-berlin.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>docevent GmbH</name>
      <address>
        <city>Schleswig</city>
        <state>Schleswig-Holstein</state>
        <zip>24837</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carsten Petersen, Dr.</last_name>
      <phone>+494621-855 425</phone>
      <email>c.petersen@internisten-schleswig.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>March 6, 2018</study_first_submitted>
  <study_first_submitted_qc>March 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2018</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Health literacy</keyword>
  <keyword>Innovation Fund</keyword>
  <keyword>lifestyle intervention</keyword>
  <keyword>risk screening</keyword>
  <keyword>type 2 diabetes mellitus</keyword>
  <keyword>Diabetes Mellitus, Type 2</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

